Literature DB >> 12656695

Bile composition in inflammatory bowel disease: ileal disease and colectomy, but not colitis, induce lithogenic bile.

S P Pereira1, I M Bain, D Kumar, R H Dowling.   

Abstract

BACKGROUND: Inflammatory bowel disease is a risk factor for gall-bladder stones, but there is controversy about the composition of these stones and whether such patients develop lithogenic bile.
METHODS: In 54 gallstone-free inflammatory bowel disease patients and 13 non-inflammatory bowel disease patients with cholesterol-rich gallstones, we measured the biliary cholesterol saturation indices, nucleation times and bilirubin concentrations, and determined the bile acid composition and molecular species of phosphatidylcholine, in gall-bladder bile.
RESULTS: Patients with Crohn's colitis or ulcerative colitis had less saturated bile (mean cholesterol saturation index, 0.9) and longer nucleation times (median, 21 days) than those with ileal Crohn's disease (1.5; 14 days) or those who had undergone colectomy (1.6; 5 days). In patients with ileal Crohn's disease, the mean biliary bilirubin concentration was two- to three-fold higher than that in the other groups, and was associated with a decrease in the percentage of biliary deoxycholate and an increase in the percentage of ursodeoxycholate, compared with disease controls, but phosphatidylcholine species were similar.
CONCLUSIONS: Patients with small bowel Crohn's disease, or who have undergone colonic resection, have supersaturated bile and an increased risk of cholesterol gallstone formation. In patients with ileal disease, the presence of high biliary bilirubin concentrations and low percentage of deoxycholic acid may also favour the formation of mixed, pigment-rich, gallstones.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12656695     DOI: 10.1046/j.1365-2036.2003.01529.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  18 in total

1.  Do steroids ameliorate bile acid malabsorption in Crohn's disease?

Authors:  R S Kwon; M C Carey
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

2.  Risk of duodenal cancer in patients with familial adenomatous polyposis.

Authors:  G Biasco; M A Pantaleo; G Di Febo; C Calabrese; G Brandi; S Bülow
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

3.  Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.

Authors:  Mireia Lopez-Siles; Margarita Martinez-Medina; Carles Abellà; David Busquets; Miriam Sabat-Mir; Sylvia H Duncan; Xavier Aldeguer; Harry J Flint; L Jesús Garcia-Gil
Journal:  Appl Environ Microbiol       Date:  2015-08-21       Impact factor: 4.792

4.  Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis.

Authors:  Annika Gauss; Robert Ehehalt; Wolf-Dieter Lehmann; Gerhard Erben; Karl-Heinz Weiss; Yvonne Schaefer; Petra Kloeters-Plachky; Adolf Stiehl; Wolfgang Stremmel; Peter Sauer; Daniel Nils Gotthardt
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 5.  Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.

Authors:  Mireia Lopez-Siles; Sylvia H Duncan; L Jesús Garcia-Gil; Margarita Martinez-Medina
Journal:  ISME J       Date:  2017-01-03       Impact factor: 10.302

6.  Crohn's disease as an immunodeficiency.

Authors:  Bu'Hussain Hayee; Farooq Z Rahman; Gavin Sewell; Andrew M Smith; Anthony W Segal
Journal:  Expert Rev Clin Immunol       Date:  2010-07       Impact factor: 4.473

Review 7.  Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

8.  Prevalence of cholelithiasis in patients with chronic inflammatory bowel disease.

Authors:  Wolfgang Kratzer; Mark-M Haenle; Richard-A Mason; Christian von Tirpitz; Volker Kaechele
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

9.  Reply to Dai et al.

Authors:  Anders Mark-Christensen; Jacob Rosenberg; Niels Qvist; Ole Thorlacius-Ussing
Journal:  Am J Gastroenterol       Date:  2017-07       Impact factor: 10.864

10.  Restorative proctocolectomy for ulcerative colitis: impact on lipid metabolism and adipose tissue and serum fatty acids.

Authors:  Marco Scarpa; Giovanna Romanato; Enzo Manzato; Cesare Ruffolo; Raffaella Marin; Silvia Basato; Sabina Zambon; Teresa Filosa; Silvia Zanoni; Fabio Pilon; Lino Polese; Giacomo C Sturniolo; Davide F D'Amico; Imerio Angriman
Journal:  J Gastrointest Surg       Date:  2007-10-23       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.